Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.61 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.56 |
| ▸ | GNRHR | P30968 | 1/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.54 |
| ▸ | GLP1R | P43220 | 1/20 | 0.53 |
| ▸ | MC4R | P32245 | 2/20 | 0.53 |
| ▸ | MC5R | P33032 | 2/20 | 0.53 |
| ▸ | MC3R | P41968 | 2/20 | 0.53 |
| ▸ | MC1R | Q01726 | 2/20 | 0.53 |
| ▸ | CTSL | P07711 | 2/20 | 0.53 |
| ▸ | CTSS | P25774 | 2/20 | 0.53 |
| ▸ | CTSK | P43235 | 2/20 | 0.53 |
| ▸ | CTSH | P09668 | 1/20 | 0.53 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391874 | 0.96 | C5AR1 (0.59) | C5AR1ABCC2GNRHRCXCR4GLP1R | |
| Acetic Acid SCHEMBL29811007 | 0.96 | C5AR1 (0.64) | C5AR1ABCC2GNRHRCXCR4MC4R | |
| SCHEMBL11033870 | 0.96 | C5AR1 (0.65) | C5AR1ABCC2GNRHRCXCR4MC4R | |
| Acetic Acid SCHEMBL29810985 | 0.93 | C5AR1 (0.64) | C5AR1ABCC2GNRHRCXCR4MC4R | |
| SCHEMBL29459900 | 0.93 | C5AR1 (0.65) | C5AR1ABCC2GNRHRCXCR4MC4R | |
| SCHEMBL30181849 | 0.92 | C5AR1 (0.59) | C5AR1ABCC2GNRHRCXCR4GLP1R | |
| SCHEMBL30271248 | 0.92 | C5AR1 (0.64) | C5AR1ABCC2GNRHRCXCR4GLP1R | |
| SCHEMBL29942618 | 0.92 | C5AR1 (0.64) | C5AR1ABCC2GNRHRCXCR4GLP1R | |
| SCHEMBL29391110 | 0.91 | C5AR1 (0.64) | C5AR1ABCC2GNRHRCXCR4MC4R | |
| SCHEMBL34464914 | 0.91 | GNRHR (0.60) | C5AR1ABCC2GNRHRCXCR4KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3570866-B1 | NOVEL USE OF KNOWN COMPOUNDS- INTRACELLULAR INFECTIONS | ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL (SE) | 2023-05-10 | — | — | EP | disclosed |
| US-11304990-B2 | Use of known compounds—intracellular infections | ISR Immune System Regulation Holding AB (publ) (SE) | 2022-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11304990-B2 | Use of known compounds—intracellular infections | NFATC1, TFEB, SQSTM1 | C5AR1 2944/4885ABCC2 1413/4885GNRHR 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.